GLP-1 and Retatrutide

---

ShiLai™ Peptide Technologies is a leading peptide manufacturer specializing in the development and large-scale production of GLP-1 receptor agonists, including the advanced multi-receptor peptide Retatrutide. As a factory-direct supplier, we serve global biotech firms, CROs, and pharmaceutical companies with high-purity peptides, produced under strict quality control and optimized for research, formulation, and preclinical development.

GLP-1 peptides such as Semaglutide, Liraglutide, and Tirzepatide have transformed the treatment landscape for type 2 diabetes and obesity. Retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, represents the next generation of metabolic disease therapies — and we are proud to offer reliable B2B access to this promising molecule.

• In-house peptide synthesis with GMP-like protocols
   
• Custom and bulk manufacturing (mg to kg scale)
   
• Full analytical data: COA, HPLC, MS, NMR available
   
• Global shipping with export documentation
   
• Dedicated B2B support for GLP-1 and Retatrutide supply

Contact ShiLai™ Peptide Technologies today for a quote, technical data sheet, or customized peptide solution. 

Running a holiday sale or weekly special? Definitely promote it here to get customers excited about getting a sweet deal.

Have you opened a new location, redesigned your shop, or added a new product or service? Don't keep it to yourself, let folks know.

Customers have questions, you have answers. Display the most frequently asked questions, so everybody benefits.